Melanoma is one of the most often reported and lethal donor derived malignancies but nature’s own unfortunate experiment may hold the answer to mysterious behaviour in the sentinel node.
Staistical errors continue to hamper progress in the MSLT-1 trial looking at the potential role of sentinel node biopsy in the treatment of malignant melanoma.
Regular ultrasound surveillance of lymph nodes is an alternative to sentinel node biopsy. It offers an effective non-invasive method of monitoring disease activity. We explore reasons to use this modality.
Sentinel Node Biopsy has been accepted into everyday Melanoma practice, but we explore the evidence base for this procedure, exposing why it may not offer the advantages sometimes promised by clinicians.